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ABSTRACT
Objective: To determine the prevalence of contrast-induced nephropathy in cardiac patients undergoing 
diagnostic and / or treatment angiographic procedures. Method: A prospective, quantitative study in the 
hemodynamics sector of a large hospital, located in the northern region of Rio Grande do Sul, Brazil. 
The sample consisted of 79 participants through the calculation of sample size. Results: The sample consisted of 
52 (65.8%) men and 27 (34.2%) women. The mean age was 65.9 ± 9.52 years. The incidence of contrast-induced 
nephropathy was 30,38%, totaling 24 patients. Conclusion: A high prevalence of contrast nephropathy was 
evidenced, despite the fact that patients presented few risk factors, which highlights the need for preventive 
measures and reduction of contrast volume.
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RESUMO
Objetivo: Determinar a prevalência da nefropatia induzida por contraste 
em pacientes cardiopatas submetidos a procedimentos angiográficos de 
diagnóstico e/ou tratamento. Método: Estudo prospectivo, quantitativo, 
realizado no setor de hemodinâmica de um hospital de grande porte, 
situado na região norte do Rio Grande do Sul, Brasil. A amostra foi 
constituída por 79 participantes através do cálculo de tamanho amostral. 
Resultados: A amostra foi formada por 52 (65,8%) homens e 27 (34,2%) 
mulheres. A idade média foi de 65,9 ± 9,52 anos. A incidência de 
nefropatia induzida por contraste foi de 30,38%, totalizando 24 pacientes. 
Conclusão: Foi evidenciada uma alta prevalência de nefropatia por 
contraste, apesar dos pacientes apresentarem poucos fatores de risco, 
o que ressalta a necessidade de medidas preventivas e redução do volume 
de contraste.
Descritores: Nefropatia; Meios de contraste; Lesão renal aguda; Doença 
das coronárias; Hemodinâmica. 
RESUMÉN
Objetivo: Determinar la prevalencia de la nefropatía inducida por contraste 
en pacientes cardiopatas sometidos a procedimientos angiográficos de 
diagnóstico y / o tratamiento. Método: Estudio prospectivo, cuantitativo, 
realizado en el sector de hemodinámica de un hospital de gran porte, 
situado en la región norte de Rio Grande do Sul, Brasil. La muestra fue 
constituida por 79 participantes a través del cálculo de tamaño muestral. 
Resultados: La muestra fue formada por 52 (65,8%) hombres y 27 
(34,2%) mujeres. La edad media fue de 65,9 ± 9,52 años. La incidencia 
de nefropatía inducida por contraste fue del 30,38%, totalizando 24 
pacientes. Conclusión: Se evidenció una alta prevalencia de nefropatía 
por contraste, a pesar de que los pacientes presentaban pocos factores de 
riesgo, lo que resalta la necesidad de medidas preventivas y reducción del 
volumen de contraste.
Descriptores: Nefropatía; Medios de contraste; Lesión renal aguda; 
Enfermedad de las coronarias; Hemodinámica.
INTRODUCTION
Contrast-induced nephropathy (CIN) is a form of 
acute kidney injury that occurs in patients undergoing 
diagnostic and therapeutic medical procedures using 
iodinated contrast1. 
During last decade, CIN has been identified as 
the third leading cause of acute renal failure (ARF) in 
hospitalized patients and may reach 12% of cases. This 
complication increases mortality, morbidity, length of 
hospitalization and associated costs2-3.
CIN is defined as an absolute increase in serum 
creatinine ≥ 0.5 mg / dL or an increase of 25% relative 
to basal creatinine within 24 to 72 hours after exposure 
to the contrast agent and in the absence of another 
alternative cause4.
The volume and type of contrast used add to the 
pre-existing risk factors to determine the severity of side 
effects. High osmolarity contrasts are more nephrotoxic 
when compared to low osmolarity contrasts5.
Models that seek to elucidate the mechanism of 
CIN development are complex but point to tubular 
injury caused by direct toxicity or associated with 
oxygen free radical generation and renal arteriolar 
vasoconstriction. This decrease in vascular lumen causes 
medullary hypoxia through the release of nitric acid, 
endothelin and adenosine producing a contrast-induced 
cytotoxic effect6.
Considering the potential harmfulness of contrast 
agent-induced nephropathy, the implementation of 
effective prevention measures for this complication is 
justified, based on the profile of specific risk factors of 
patients treated at the hemodynamic sector. Given the 
above, this study aimed to determine the prevalence of 
CIN in heart disease patients undergoing angiographic 
diagnostic and / or treatment procedures.
METHODOLOGY
This is a prospective, quantitative study conducted in 
the hemodynamics sector of a large hospital located in the 
northern region of Rio Grande do Sul, Brazil, from May 1 
to September 28, 2018.
Eligibility criteria included adult patients of both 
genders with heart disease who underwent angiographic 
procedures for diagnosis and / or treatment in the 
hemodynamics department who were hospitalized for 
at least 72 hours after the procedures. Patients who had 
incomplete data and/or died before the end of the period 
of 72 hours after the use of contrast were excluded.
To determine the sample size of this research, a sample 
size calculation was performed, with an error of 5%; 90% 
confidence level; population of 253 patients, maximum 
percentage of CIN 12%, totaling a sample of 79 individuals.
The primary outcome of the study was the development 
of CIN, verified by creatinine variation 24 to 72 hours 
after the use of contrast. The secondary outcome was the 
proportion of risk factors through the stratification score.
Data were collected from interviews with patients, 
analysis of medical records and laboratory tests. 
The variables evaluated were: age, blood pressure, 
creatinine, hematocrit, hemoglobin, glomerular filtration 
rate (GFR), weight, height, body mass index (BMI), 
comorbidities, smoking, procedure performed, contrast 
volume, use of measurements. preventive measures, 
creatinine at 24, 48 and 72 hours after administering 
contrast, post-procedural complications and patient 
discomfort with contrast administration.
The risk of developing CIN and the need for dialysis 
was performed using the Mehran Stratification Score7. 
Secondary data (medical records) were used to confirm 
the following: age, sex, hematocrit, presence of intra-
aortic balloon, contrast volume, diabetes mellitus (DM), 
hypotension, congestive heart failure (CHF) and GFR. 
The score was assessed within the first 24 hours after the 
contrast procedure.
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The type of contrast used was the same for all 
patients, Ultravist® (iopromide) 300, Bayer laboratory, 
with osmolarity equal to 0.64 Osm / kgH2O at 37ºC 
used intravascularly8.
The diagnoses of systemic arterial hypertension (SAH), 
stroke, DM and CHF were included according to data 
contained in the medical records. GFR was determined 
based on serum creatinine using the Chronic kidney 
Disease Collaborative Epidemiology (CKD-EPI) equation. 
Hypotension was considered to be systolic blood pressure 
below 80mmHg. Anemia, hematocrit <39% if male and 
<36% if female. Renal insufficiency (RI) was defined as 
creatinine prior to examination greater than or equal to 
1.4 mg / dL.
For data analysis, the SPSS (Statistical Package 
for Social Sciences) version 25.0 for Windows, Brazil 
was used. The significance level adopted was p≤0.05. 
Data were exported and tabulated in a spreadsheet using 
Excel, version 15.0 for Windows, Brazil, twice by same 
typist, later the data were compared. The discrepancies 
were verified and corrected based on the collection 
instrument and medical records.
Continuous variables were described as mean and 
standard deviation (SD); categorical variables such as 
frequency and percentage. To compare a continuous 
variable between two groups, Student’s t-test and Mann-
Whitney test were used.
The study was approved by the institution of the 
collection and later by the Research Ethics Committee (CEP) 
of the University of Passo Fundo (UPF), under protocol 
No. 2,572,548 and CAAE No. 84987518.0.0000.5342, 
in compliance with ethical and legal principles in line 
with the Resolution No. 466/2012 of the National Health 
Council9. Study participants signed the Informed Consent 
Form (ICF) shared before data collection.
RESULTS 
We studied 79 patients who underwent diagnostic 
and / or contrast treatment in the hemodynamic sector, 52 
(65.8%) males and 27 (34.2%) females. The average age of the 
participants was 65.9 ± 9.52 years. No patient in the study 
underwent dialysis therapy at least 72 hours after contrast 
use. The prevalence of CIN was 30.38%, totaling 24 patients.
During the research, we found that 51 (64.6%) patients 
who underwent contrast procedures did not receive 
prophylactic measures related to CIN prevention, while 28 
(35.4%) received saline hydration (SF) 0.9 % intravenously.
There was no significant difference between basal 
creatinine values in patients with and without CIN. 
Serum creatinine values after the procedure were higher 
among patients who developed CIN within 48 to 72 hours 
of contrast use, as shown in Table 1.
When comparing patients with and without CIN, patients 
who developed nephropathy were more hypertensive, had a 
higher percentage of reduced left ventricular ejection fraction 
(EF), and a higher incidence of CHF. Interestingly, patients 
with prior IR developed less CIN. The other comparisons 
of clinical and demographic variables did not differ and are 
presented in table 1.
Table 1 - Comparison between patients with and without Contrast-induced nephropathy (CIN). Passo Fundo, RS, Brazil, 2018
Variables Without CIN n=55 (69,62%)
With CIN 
n=24 (30,38%) P
Age (years) 65,34 ± 9,57 67,25 ± 9,47 0,68*
Men 36 (65,5%) 16 (66,7%) 0,83*
Body Mass Index (Kg / m2) 27,09 ± 3,81 27,24 ± 4,03 0,61*
Risk factors for CIN
HAS 42 (74,5%) 20 (83,2%) 0,030*
Hypotension 9 (16,4%) 3 (12,%) 0,37*
DM 16 (29,1%) 7 (29,2%) 0,98*
Dyslipidemia 17 (30,9%) 3 (12,5%) < 0,001*
DAC 16 (29,1%) 7 (29,2%) 0,75*
Arrhythmias 3 (5,5%) 5 (20,8%) 0,10*
Previous stroke 11 (20%) 2 (8,3%) 0,34*
EF <50% 13 (23,6%) 9 (37,5%) 0,006*
Smoking 17 (30,9%) 4 (16,7%) 0,15*
Former smoker 6 (10,9%) 8 (33,3%) 0,68*
ICC 1 (1,8%) 7 (29,2%) < 0,001*
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The contrast volume used ranged from 50 to 500mL, 
with a mean volume of 171.97 ± 91.27mL. Patients 
undergoing catheterization (CAT) followed by percutaneous 
transluminal coronary angioplasty (ACTP) received a higher 
contrast volume, as shown in table 2.
Table 2 - Type of procedure and contrast volume. Passo 
Fundo, RS, Brazil, 2018
Procedure Frequency Volume (mL)
CAT 29 ( 36,7%) 110,86 ± 56,30
ACTP 8 (10,1%) 225 ± 132,23
CAT + ACTP 27 (34,2%) 232,96 ± 62,80
CAT + AORTO 15 (19%) 152,06 ± 84,08
CAT: catheterization; PTCA: percutaneous transluminal coronary 
angioplasty; AORT: Aortography.
Of the total patient sample, 46.6% (n = 36) mentioned 
some type of discomfort after contrast administration. 
The most cited were heat 29.1% (n = 23), nausea 5.1% (n = 4) 
and 11.4% (n = 9) reported feeling both symptoms.
The CIN risk stratification score was performed for 
patients undergoing angiographic procedures that were 
part of the study. The group of patients who developed 
CIN had higher score, respectively, 8.17 ± 4.67 versus 
6.60 ± 5.08 (p = 0.12).
Patients who developed CIN had more complications 
after the procedures, corresponding respectively to 25% 
(n = 6) versus 3.6% (n = 2); (p = ≤ 0.001). Among the 
complications, the most frequent was cardiopulmonary 
arrest (CRP) 5.1% (n = 4), followed by arrhythmias 3.8% 
(n = 3) and hypotension 1.3% (n = 1).
DISCUSSION
Constant evolution of science and technologies in health, 
through modern, complex and sophisticated equipment, 
allow high quality imaging for early diagnosis and treatment 
of diseases9. Diagnostic and imaging procedures, such 
as arteriography and coronary angiography, may cause 
adverse events such as CIN10.
CIN, often underdiagnosed, is considered the third 
cause of ARF in a hospital setting, and may correspond to 
12% of cases, remaining behind only prerenal and drug-
induced ARF2-3. In this study, a higher prevalence was 
observed, corresponding to 30.38% (n = 24) of the patients.
Regarding the prevalence and clinical relevance of 
CIN, prevention would be the ideal approach. However, 
due to ineffective prophylactic measures and difficulty 
in establishing specific biomarkers, early diagnosis is the 
best alternative for treatment efficacy11.
The prevalence of CIN depends on the factors related 
to the technique (type of contrast, volume and osmolarity) 
and is associated with pre-existing risk factors: decreased 
renal function, age over 75 years, DM, hypotension, 
CHF, intra-aortic balloon implantation (IAB), anemia 
and dehydration12. The most significant risk factors for 
CIN observed in our study were CHF and reduced EF. 
The association between CHF and CIN may be due to the 
characteristic aspects of these patients: low cardiac output 
and high catecholamine levels, which result in reduced 
renal perfusion13.
In the present study, we observed that the institution 
where the research was conducted presents weaknesses in 
compliance with measures standardizing the prevention 
of acute kidney injury after the use of contrast media. 
Variables Without CIN n=55 (69,62%)
With CIN 
n=24 (30,38%) P
GO 9 (16,4%) 1 (4,2%) 0,001*
Anemia 20 (36,4%) 14 (58,3%) 0,43*
PAS 120,09 ± 21,56 130,92 ± 31,04 0,054*
Preventive Measures and Creatinine Levels 70,16 ± 12,22 76,42 ± 17,28 0,033*
Contrast Volume (ml)
Pre procedure hydration 154,11 ± 81,53 212,92 ± 100,67 0,007**
TFG 21 (38,2%) 7 (29,2%) 0,098*
Cr Basal 61,33 ± 19,73 71,01 ± 24,39 0,23*
Cr 24 1,30 ± 0,57 1,01 ± 0,38 0,26*
Cr 48 1,26 ± 0,54 1,21 ± 0,50 0,67*
Cr 72 1,20 ± 0,49 1,37 ± 0,56 0,12*
Cr 72 1,18 ± 0,49 1,30 ± 0,44 0,53*
Result in mean ± standard deviation and percentages in parentheses. * Student t test, ** Mann - Whitney test.
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Only 35.4% (n = 28) of the patients received intravenous 
hydration with 0.9% SF prior to contrast use. There is also 
no standardization of the records of contrast volume used.
Annotations regarding the type and volume of 
contrast used are of utmost importance, as contrast use 
has been cited as one of the most common causes of acute 
renal dysfunction, and the lack of this information may 
negatively interfere with possible management of CIN 
prevention. The volume and type of contrast used add 
to the pre-existing risk factors to determine the severity 
of side effects5.
According to the literature, the cut-offs at risk for 
infused contrast volume is <200ml14-15. In the present 
study, the mean volume infused in patients who developed 
CIN was 212.92 ± 100.67mL, above the recommended 
cut-off point.
There is evidence of the benefit of using low osmolarity 
or nonionic isosmolar contrasts in the prevention of CIN 
in higher risk patients. Prophylactic use of N-acetylcysteine 
is still controversial in the literature. A proven effective 
measure is hydration with 0.9% SF 1mL / kg / hour 12 
hours before and after the procedure16.
Although most often reversible, CIN is associated 
with increased morbidity, prolonged stay at the medical 
facility, high hospital costs, and higher chances of death 
even without hemodialysis. CIN is known to increase by 
14.4% the 30-day death rate and by 17.4% after the three-
year period17. In this study, a high complication rate was 
observed after the contrast procedures, corresponding 
to 25%.
In this context, the previous intervention of nurses 
and the performance of a multiprofessional team in 
interventional cardiology seek to promote excellence 
in care, favor rapid recovery and minimize negative 
impacts on the individual’s quality of life. Such conduct 
contributes to the reduction of hospital costs, contributes 
to effective and comprehensive care18.
As limitations of the study, the first is short patient 
follow-up period, which made it impossible to identify 
the adverse outcome, whether death or complications, 
in the medium and long term. Second limitation is the 
lack of compliance with the CIN protocol as well as data 
recording routines related to the contrast exams.
Further prospective studies are considered extremely 
important in the institution so that the existing protocol 
can be implemented, thus avoiding the risk of evolution 
to chronic condition or even CIN.
CONCLUSION
The results of this study demonstrated a high prevalence 
of CIN in patients undergoing contrast procedures 
and, in most cases, they exhibited few risk factors. 
CHF and reduced EF were statistically significant risk 
factors for the development of nephropathy. A high dose 
of contrast volume has been observed in the procedures, 
especially the therapeutic ones.
The high prevalence of CIN indicates the need reduce 
contrast volumes and to use protocols of prevention before 
and after contrast-enhanced examinations, thus increasing 
patient safety.
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